GoodRx (GDRX) capital expenditure was $74M in FY2025 (+5% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$74M
+5%
2024
$70M
+26%
2023
$56M
+1%
2022
$55M
+60%
2021
$34M
-4%
2020
$36M
+523%
2019
$6M
+66%
2018
$3M
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q2 2026
$14M
Q1 2026
$22M
Q4 2025
$16M
Q3 2025
$18M
Q2 2025
$18M
Q1 2025
$22M
Q4 2024
$17M
Q3 2024
$16M
Q2 2024
$17M
Q1 2024
$21M
Q4 2023
$13M
Q3 2023
$14M
Source: GDRX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.